Sort   by:  
 Page size 
MetabolomicsIntegrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency
Functional oncogenic links between ErbB2 and ERRα in HER2+ breast cancer patients support a therapeutic benefit of co-targeted therapies. However, ErbB2 and ERRα also play key roles in heart physiology, and this approach could pose a potential liability to cardiovascular health. Herein, using integr...
2022-09-20 | MTBLS795 | MetaboLights
UnknownCharacterization of vascular disease risk in postmenopausal women and its association with cognitive performance.
Not available
S-EPMC3714288 | biostudies-literature
UnknownThe KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition.
Not available
S-EPMC4367860 | biostudies-literature
UnknownDeleterious variants in intolerant genes reveal new candidates for self-limited delayed puberty.
Not available
S-EPMC12013340 | biostudies-literature
UnknownEffects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
Not available
S-EPMC4452757 | biostudies-literature
UnknownPrevalence of Deleterious Variants in MC3R in Patients With Constitutional Delay of Growth and Puberty.
Not available
S-EPMC10655545 | biostudies-literature
UnknownSARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster.
Not available
S-EPMC8722594 | biostudies-literature
UnknownGenetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes.
Not available
S-EPMC4392920 | biostudies-literature
UnknownSARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies.
Not available
S-EPMC8995032 | biostudies-literature
ProteomicsA dataset describing a suite of novel antibody reagents for the RAS signaling network
RAS genes are frequently mutated in cancer and have for decades eluded effective therapeutic attack. The National Cancer Institute’s RAS Initiative has a focus on understanding pathways and discovering therapies for RAS-driven cancers. Part of these efforts is the generation of novel reagents to ena...
ORGANISM(S): Homo Sapiens 
PXD012604 | panorama
Sort   by:  
 Page size